Immediate Impact
55 standout
Citing Papers
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
2023 Standout
Works of D Sinagra being referenced
Visceral adiposity index is associated with significant fibrosis in patients with non‐alcoholic fatty liver disease
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| D Sinagra | 128 | 22 | 48 | 126 | 65 | 24 | 311 | |
| Laura Rivoli | 62 | 15 | 52 | 40 | 54 | 20 | 327 | |
| Fahri Güneş | 85 | 21 | 103 | 63 | 108 | 31 | 337 | |
| Evangelia Makri | 104 | 9 | 53 | 208 | 47 | 16 | 309 | |
| Ting-Yao Wang | 110 | 8 | 36 | 235 | 46 | 21 | 362 | |
| Min Ho Cho | 123 | 23 | 68 | 85 | 82 | 25 | 348 | |
| Marija Branković | 45 | 5 | 65 | 107 | 16 | 29 | 294 | |
| Yong Jin Cho | 77 | 15 | 36 | 84 | 49 | 21 | 340 | |
| Teslime Ayaz | 90 | 13 | 49 | 44 | 27 | 40 | 318 | |
| Yanlan Fang | 154 | 21 | 90 | 259 | 43 | 22 | 369 | |
| Zbigniew Wierzbicki | 43 | 16 | 42 | 61 | 28 | 23 | 369 |
All Works
Loading papers...